Has Richard Millstein, DO received payments from drug or device companies?

Yes. Drug and device makers reported $3,452 in general payments to Richard Millstein, DO across 21 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Richard Millstein, DO did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Richard Millstein, DO come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Richard Millstein, DO

Endocrinology, Diabetes & Metabolism · Greeley, CONPI 1407101975

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $2,409 of the $3,452 with a category attached, or 69.8%. Insulet Corporation accounts for 64.4% of it on its own, with 5 other manufacturers making up the rest. 2025 is the largest year on record at $2,130, 2.7 times the $784 reported in 2019.

$3,452in general payments, 2019–2025

Across 21 payments — averaging $164.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Insulet Corporation$2K
Tandem Diabetes Care, Inc.$784
BETA Bionics, Inc.$218
Mannkind Corporation$186
Dexcom, Inc.$27
Bristol Myers Squibb$14

$89,940in research payments, 2019–2025

Across 231 payments — averaging $389.35 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Ascendis Pharma Endocrinology Inc$90K

What the payments were for

Travel & lodging$2,40970%
Food & beverage$98328%
Gifts$592%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Insulet Corporation	11	$2,224
Tandem Diabetes Care, Inc.	5	$784
BETA Bionics, Inc.	1	$218
Mannkind Corporation	2	$186
Dexcom, Inc.	1	$27
Bristol Myers Squibb	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,452 in reported general payments places this provider in the 70th percentile of 120 endocrinology, diabetes & metabolism providers in Colorado.

See all endocrinology, diabetes & metabolism providers in Colorado →

Medicare billing

Part B allowed, 2024

$131,410

Medicare patients

334

Services billed

5,813

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
OzempicSemaglutide	244	$459,315
MounjaroTirzepatide	225	$369,115
JardianceEmpagliflozin	253	$359,676
TrulicityDulaglutide	116	$218,898
MycapssaOctreotide Acetate	13	$172,312
Tresiba Flextouch U-200Insulin Degludec	89	$150,129
Xultophy 100-3.6Insulin Degludec/Liraglutide	53	$149,788
Tresiba Flextouch U-100Insulin Degludec	117	$100,696
Humulin R U-500 KwikpenInsulin Regular, Human	55	$97,062
JanuviaSitagliptin Phosphate	71	$91,549
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog	37	$88,205
Soliqua 100-33Insulin Glargine/Lixisenatide	28	$68,619
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog	57	$66,720
Humalog Kwikpen U-200Insulin Lispro	28	$66,050
Lantus SolostarInsulin Glargine,hum.Rec.Anlog	327	$65,688

Paid to pharmacies, not to this prescriber.

Other endocrinology, diabetes & metabolism in Greeley

James SpeedGreeley$2K
Leigh PerreaultBoulder$1.7M
Satish GargAurora$347K
Viralkumar ShahAurora$256K
Neda RasouliAurora$188K
Michelle CassaraArvada$141K
Halis AkturkAurora$109K
Irinel StanciuArvada$104K
Robert EckelAurora$66K
Marc Andre CornierAurora$62K

See the full list for Colorado →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →